Eingabe löschen

Kopfbereich

Hauptnavigation

Adcancing drug development: 3D CoSeedis Immuno-Micro-Tumor System

Beschreibung

This collaboration between abc biopply, ZHAW Zurich University of Applied Sciences, and University of Zurich aims to advance drug development by introducing a novel 3D CoSeedis Immuno-Micro-Tumor System.

The new system will encompass heterotypic cancer organoids, consisting of cancer, stromal and immune cells, embedded in an extracellular matrix, which offer a physiologically relevant microenvironment for testing new immunotherapies.

Eckdaten

Projektleitung

Projektteam

Projektpartner

Universität Zürich; abc biopply ag

Projektstatus

laufend, gestartet 09/2025

Institut/Zentrum

Institut für Chemie und Biotechnologie (ICBT)

Drittmittelgeber

Innosuisse Innovationsprojekt